Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1674 | Thyroid (non-cancer) | ICEECE2012

Decreased echogenicity and increased vascularization of fetal thyroid on 2D-ultrasonography caused by mother’s Graves’ disease

Gietka-Czernel M. , Debska M. , Kretowicz P. , Jastrzebska H. , Wasniewska G.

Fetal ultrasonography is recommended in pregnant women with elevated TSH receptor antibodies (TRAK) or treated with antithyroid drugs in attempt to recognize fetal thyroid dysfunction. We report two cases of pregnant women with Graves’ disease in whom fetal thyroid ultrasonography was especially useful in diagnosing child involvement.A 33-year-old woman at 30-week pregnancy with 3-months history of hyperthyroidism treated with propylothiouracil (PTU...

ea0014p380 | (1) | ECE2007

Adiponectin in patients with Graves’ ophthalmopathy (GO)

Jastrzebska Helena , Gietka-Czernel Malgorzata , Janik Jadwiga , Czajka-Oraniec Izabella , Jeske Wojciech , Karczmarzyk Regina , Zgliczynski Wojciech

Adiponectin is a soluble protein produced solely by matured adipocytes. Adipogenesis contributes to the pathogenesis of GO in many ways including a direct effect on proptosis due to increased volume of mature adipocytes.The aim of the study was to estimate an influence of immunosupresive and anti-inflammatory treatment using systemic corticotherapy combined with orbital radiotherapy on serum adiponectin level in GO patients. The study was accepted by Eth...

ea0014p465 | (1) | ECE2007

Thyroidectomy as the last chance treatment for life threatening thyrotoxicosis: a case report

Gietka-Czernel Margaret , Jastrzebska Helena , Zgliczynski Wojciech , Dudek Agnieszka , Szczepkowski Marek

54-year old woman with Graves’ disease was admitted to Endocrinology Department because of severe thyrotoxicosis and antithyroid drugs inolerance. The apathetic form of thyrotoxicosis was diagnosed; she lost 12 kg during 3 months and she had heavy muscle weakness. Previously she demonstrated allergic skin reactions (macular rushes) after both: Methimazole and Propylthiouracil. At admission her TSH was 0.001 mU/l, fT3 24 pg/ml, fT4 37 pmol/l. Lithium, propranolol and gluco...

ea0011p902 | Thyroid | ECE2006

Corticotherapy alone or corticotherapy combined with orbital radiotherapy in severe active Graves’ ophthalmopathy: therapeutic outcome in 905 patients

Jastrzebska H , Gietka-Czernel M , Janik J , Zgliczynski S , Karczmarzyk R , Fijuth J

The aim of the study was to compare efficacy and tolerability of systemic corticotherapy alone to corticotherapy combined with orbital radiotherapy in severe active Graves’ ophthalmopathy. We studied 905 patients, aged 35–73 years (mean 58.2 ±12), with clinical activity score above 4 and ATA class 3c to 6. Therapeutic outcome was assessed by change in ophthalmopathy index. For 4 weeks all subjects received corticotherapy: 869 - oral prednisone 60–100 mg dai...

ea0011p905 | Thyroid | ECE2006

Pretreatment with rhTSH allows effective 131I therapy in patients with multinodular toxic goiter and low radioiodine uptake

Gietka-Czernel M , Jastrzebska H , Zgliczynski W , Wasniewska G , Wróblewska M , Wernic K , Cybulska B , Karpiska E

Aim: Estimation of the effectiveness of a single low dose 0.05 mg rhTSH in increasing radioiodine uptake (RAIU) before 131I therapy for multinodular toxic goiter with low initial RAIU.Patients: 24 patients (21 women, 3 men) with multinodular toxic goiter without prior antithyroid drug therapy. The initial 24 h RAIU was 21.1±8.44%; range, 6–39% and thyroid volume 64.14±22.49 ml; range, 24.8–109 ml.Meth...